Wealth-Lab Technical Analysis, Charting and Trading Systems

Your Interactive Trading Laboratory!

110 members logged in

Home

My Wealth-Lab

My Scans

Forum

User Forums

ChartScript Center

Published ChartScripts

View by Family

Code Library

DynaCharts

Slide Show

ChartScript Rankings

Most Popular

Ranking Method

Virtual Trading Game

Leaders

Manage Trades

Trader's Blog

Manage

Commentaries

Interviews

WealthScript Help

Quick Start

The Chart

With QuotesPlus you can have a complete historical stock database for your Wealth-Lab Developer back-testing!

Welcome to Wealth-Lab.com^TM, the first interactive trading system development laboratory on the web. Develop and back test your own stock market trading systems, and explore the systems contributed by other members. We rank all submitted trading systems monthly, so you see which strategies are working best in the current market conditions. Click here to learn more ...

Market Action

Wealth-Lab News (History)

A Point and Figure Charting fix is available for Wealth-Lab Pro/Developer Versions 3 or 4. (5/2/2008)

ChartScript Rankings for the period ending 2/29/2008 are complete! Click here for more information.
Note: Only one Simplicity! strategy (Take 16) remains in the Stop/Limit Order Top 25, and it too should fall off the list next month due to nearly zero exposure. (3/1/2008)

Traders Expo in New York 16-19 Feb. Join us at the Fidelity exhibit! (2/10/2008)

Fidelity Wealth-Lab Pro 5.0 is live!
Wealth-Lab Pro 5.0 represents a major step forward in trading strategy creation and backtesting technology with improved performance and design that is geared towards giving you added flexibility and efficiency. (1/10/2008)

Wealth-Lab Version 4.0 Build 4 upgrade (only) is available! Fixes for Yahoo!, MSN, and more. (10/7/2007)

Top 10 Market Order ChartScripts by Net Profit %
as of 12/28/2007
Click for Top 25 ChartScripts

Ranking	ChartScript	Net Profit %	APR	Max DD %
1	33 Liner	944.04%	52.43%	-33.51%
2	A seventeen-liner	459.44%	36.26%	-39.12%
3	A sixteen-liner	448.19%	35.77%	-39.12%
4	Adjusted ROC (Luoma & Nikkinen, SAC Apr 2007)	303.85%	28.51%	-41.75%
5	StochasticsK 95/20 + BB p10 sd 1.5	286.53%	27.50%	-18.79%
6	JC Master V2	280.91%	27.17%	-27.55%
7	StochasticsK 95-20 + BB.2	272.93%	26.69%	-35.57%
8	MACD Trades	247.37%	25.08%	-25.96%
9	Default XDev -Volumne Adjusted - ver 1.0	221.01%	23.32%	-27.79%
10	ETF TRADER top 10 v2	214.41%	22.86%	-35.55%

Wealth-Lab Developer and Wealth-Lab Pro

Build 4 is available

Are you serious about trading system development and back testing? Then you need Wealth-Lab Pro / Wealth-Lab Developer!

US and Canadian residents - click here to learn more about Wealth-Lab Pro from Fidelity Investments. WL-Pro includes seamless, streaming real time and end-of-day data provided free of charge from Fidelity (other external data providers are still supported) as well as extraordinary automated trading execution exclusive with Fidelity (for active trader clients only).
Non-US and Canadian residents - click here to learn more about Wealth-Lab Developer. This version does not include the automated trading feature, and users need to sign up with a data provider of their choice.

Quick Links:

WLD4 Information
WLD4 Downloads
WLD4 Upgrades

Top 25 ChartScripts

Past Book selections

Our Website Trading Tools

Discussion Forums
Join our 40,615 members sharing technical trading ideas and techniques.

DynaCharts
Create your own interactive charts with a great selection of technical indicators.

ChartScripts
Program your own complete trading systems with our WealthScript scripting language. Backtest your strategies on any stock that you wish.

MarketCalls
Practice your trading with a virtual trading account. You start with $100,000, and can place Market, Limit and Stop orders.

About Wealth-Lab

Support Policy

MileStones

User Comments

Important Disclaimer: The information provided by Wealth-Lab is strictly for informational purposes and is not to be construed as advice or solicitation to buy or sell any security. The owner of Wealth-Lab.com assumes no liability resulting from the use of the material contained herein for investment purposes. By using this web site, you agree to the terms of this disclaimer and our Terms of Use.